PokeAcell is an immunotherapy company with a proprietary technology for personalized T cell therapy of late stage cancer. PokeAcells proprietary technology activate and grow cancer-specific T cells present in patient’s own blood and the cells are given back to the patient as fully personalized treatment. The T cell therapy hold the promise of curative treatment in Metastatic Melanoma and Merkel Cell carcinoma – two of the most severe skin cancers today and with potential in several other indications.